SCHEDULE 13G/A: Major Shareholder Yehuda Nir Discloses 10.1% Stake in PolyPid Ltd.
Beneficial Ownership Disclosure
Yehuda Nir has filed an amended Schedule 13G, disclosing beneficial ownership of 10.1% of PolyPid Ltd.'s ordinary shares as of March 31, 2025.
Summary
- Yehuda Nir beneficially owns 1,071,258 ordinary shares of PolyPid Ltd.
- This ownership represents 10.1% of the company's outstanding ordinary shares.
- The reported stake includes 457,351 ordinary shares underlying currently exercisable warrants held by Mr. Nir.
- The percentage is calculated based on 10,190,904 ordinary shares of PolyPid Ltd. outstanding as of February 26, 2025, as reported in the company's Annual Report on Form 20-F, plus the additional shares from Mr. Nir's warrants.
- The filing date for this Schedule 13G Amendment No. 2 is May 15, 2025, with the event date requiring the filing being March 31, 2025.
Sentiment
Score: 6
Explanation: The document is a routine disclosure of a significant passive ownership stake, which is generally viewed as neutral to slightly positive as it indicates continued investor confidence without intent to influence control.
Positives
- A significant individual shareholder, Yehuda Nir, holds a substantial 10.1% stake in PolyPid Ltd., indicating continued confidence in the company.
- The filing explicitly states that the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer, suggesting a passive and stable investment stance.
Future Outlook
NA
Management Comments
- "To the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11." (Statement by Yehuda Nir)
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant individual holding, which may reinforce confidence in the company's stability given the passive nature of the investment.
Key Dates
| Date | Description |
|---|---|
| 02/26/2025 | Date as of which 10,190,904 ordinary shares of PolyPid Ltd. were outstanding, based on the Issuer's Annual Report on Form 20-F. |
| 03/31/2025 | Date of event which requires the filing of this statement. |
| 05/15/2025 | Date of signature and filing of the Schedule 13G Amendment No. 2. |
Keywords
PolyPid Ltd., Yehuda Nir, Schedule 13G, beneficial ownership, ordinary shares, SEC filing, shareholder, investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.